Prognostic significance of MYCN gene amplification and protein expression in primary brain tumors: Astrocytoma and meningioma.

about

Prognostic significance of MYCN gene amplification and protein expression in primary brain tumors: Astrocytoma and meningioma.

Item

http://www.wikidata.org/entity/Q50692461

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@en

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@nl

type

Item

label

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@en

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@nl

prefLabel

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@en

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@nl

P1476

Prognostic significance of MYC ...... s: Astrocytoma and meningioma.

@en

P2093

Firouzeh Javan

http://www.w3.org/2001/XMLSchema#string

Masoud Mehrazin

http://www.w3.org/2001/XMLSchema#string

Mehrdad Asghari Estiar

http://www.w3.org/2001/XMLSchema#string

Parvin Mehdipour

http://www.w3.org/2001/XMLSchema#string

P2860

NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Epidemiology of primary CNS tumors in Iran: a systematic review

Survival and low-grade glioma: the emergence of genetic information

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.

N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.

MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma

MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma.

P304

341-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-160546

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ali Zekri

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28453467

http://www.w3.org/2001/XMLSchema#string